Shinan Wu

14PUBLICATIONS
26CO-AUTHORS
Molecular medicineMortalityPharmacology and pharmaceutical sciences not elsewhere classifiedPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 07, 2026
A ROS-Responsive and Mucoadhesive Thermosensitive Hydrogel Encapsulated with Mizoribine for Synergistic Dry Eye Therapy.

|Sep 25, 2026
Changing Epidemiology of Refractive Disorders in the Western Pacific Region, 1990-2023: Evidence From the Global Burden of Disease Study 2023.

|Oct 10, 2025
Drug-related retinal detachment pharmacovigilance signals in the real world: evidence from the FDA Adverse Event Reporting System.

Xiao-Dong Chen, Kun-Hong Xiao, Shi-Nan Wu

|Sep 25, 2025
Real-world large sample evaluation of drug-related blepharoptosis: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database.

Kunhong Xiao, Xiaodong Chen, Shinan Wu

|Dec 23, 2024
Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database.

Rongqiang Liu, Yukai Chen, Shi-Nan Wu

|Oct 26, 2024
Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database.

Shi-Nan Wu, Xiao-Dong Chen, Dan Yan

Pageof 3

Frequent Collaborators

5 joint publications

Yi Shao

2 joint publications

Zuguo Liu

1 joint publications

Meng-Yao Zhang

1 joint publications

Hui-Ye Shu